Thank you for previously screening with Cologuard

The American Cancer Society recommends a screening interval every 3 years with Cologuard following a negative result.1

Check back again when it's time to screen.

For questions, visit customer support.

Reference
1. Wolf AMD, Fontham ETH, Church TR, et al. 2018. Colorectal Cancer Screening for Average-Risk Adults: 2018 Guideline Update From the American Cancer Society.

Cologuard is intended to screen adults 45 years of age and older who are at average risk for colorectal cancer by detecting certain DNA markers and blood in the stool. Do not use if you have had adenomas, have inflammatory bowel disease and certain hereditary syndromes, or a personal or family history of colorectal cancer. Cologuard is not a replacement for colonoscopy in high risk patients. Cologuard performance in adults ages 45-49 is estimated based on a large clinical study of patients 50 and older.

The Cologuard test result should be interpreted with caution. A positive test result does not confirm the presence of cancer. Patients with a positive test result should be referred for colonoscopy. A negative test result does not confirm the absence of cancer. Patients with a negative test result should discuss with their doctor when they need to be tested again. False positives and false negative results can occur. In a clinical study, 13% of people without cancer received a positive result (false positive) and 8% of people with cancer received a negative result (false negative). Rx only.